نتایج جستجو برای: prostate carcinomaو prostate specific antigen
تعداد نتایج: 1258516 فیلتر نتایج به سال:

 CADTH recommends that Pluvicto should be reimbursed by public drug plans for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) if certain conditions are met.
 only covered to treat prostate-specific membrane antigen (PSMA)-positive mCRPC who have received previous at least 1 androgen receptor pathway inhibitor (ARPI) and taxane-containing regimen...
To the Editor. Oesterling published an extensive review on the clinical usefulness of prostate specific antigen (PSA) [1] and updated the study in 1994. Although both reviews cover adequately clinical and basic aspects of PSA in the area of urology, important new information on PSA was not mentioned. We with to supplement the recent review with articles published in 1994 showing that PSA can no...
BACKGROUND Cytotoxic T cells (CTL) are considered one of the primary effector cell populations in antitumor immunity. Recent studies, however, have demonstrated the critical importance of helper T cells (Th), specifically interferon gamma (IFN gamma)-secreting Th1 cells, either by supporting an appropriate CTL environment or by recruiting other effector cells. We evaluated whether patients with...
Percent free prostatic-specific antigen (%fPSA) has been introduced as a tool to avoid unnecessary biopsies in patients with a serum PSA level of 4.0-10.0 ng ml-1 , however, it remains controversial whether %fPSA is effective in PSA range of 10.1-20.0 ng ml-1 in both Chinese and Western population. In this study, the diagnostic performance of %fPSA and serum PSA in predicting prostate cancer (P...
PURPOSE Little is known about the effects of literacy levels on prostate cancer screening. This study evaluates the association between literacy, compliance with screening, and biopsy findings in a large Brazilian screening study. MATERIALS AND METHODS We analyzed 17,571 men screened for PCa with digital rectal examination (DRE) and total and free prostate-specific antigen (PSA) from January ...
OBJECTIVE To assess whether Free/Total prostate specific antigen (PSA) would enhance prostate cancer detection in men with total serum PSA between 2.5 and 10 ng/ml. METHODS This case control study was conducted in the Department of Urology and Renal Transplantation, Jinnah Hospital, Lahore from January 2001 to June 2004. A total of 200 consecutive patients with symptoms of prostate disease, a...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید